|
GS136711: susceptibility to lung cancer 12 (Sluc12, Published QTL Chr 12)
|
|
GS193462: GO:0016667 oxidoreductase activity, acting on a sulfur group of donors
|
|
GS201949: GO:0044699 single-organism process
|
|
GS173213: HP:0003281 Increased serum ferritin
|
|
GS135735: delta power in slow-wave sleep 2 (Dps2, Published QTL Chr 12)
|
|
GS178461: GO:0009987 cellular process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS192041: GO:0043169 cation binding
|
|
GS178388: GO:0055114 oxidation-reduction process
|
|
GS135566: cytokine deficiency colitis susceptibility 8 (Cdcs8, Published QTL Chr 12)
|
|
GS193268: GO:0005575 cellular_component
|
|
GS196934: GO:0065008 regulation of biological quality
|
|
GS207581: GO:0007275 multicellular organismal development
|
|
GS181962: GO:0016491 oxidoreductase activity
|
|
GS205002: GO:0048856 anatomical structure development
|
|
GS181178: GO:0045454 cell redox homeostasis
|
|
GS135531: Cyp7a1 mRNA level QTL (C7mlq, Published QTL Chr 12)
|
|
GS176042: HP:0011030 Abnormality of transition element cation homeostasis
|
|
GS128594: Average rotarod training latency Chr# 12
|
|
GS207864: GO:0009055 electron carrier activity
|
|
GS135390: body growth early QTL 11 (Bgeq11, Published QTL Chr 12)
|
|
GS178718: GO:0015035 protein disulfide oxidoreductase activity
|
|
GS176735: HP:0010929 Abnormality of cation homeostasis
|
|
GS191106: GO:0044464 cell part
|
|
GS192225: GO:0051537 2 iron, 2 sulfur cluster binding
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS135254: adiposity 6 (Adip6, Published QTL Chr 12)
|
|
GS201251: GO:0044424 intracellular part
|
|
GS127205: Tamoxifen interacting genes (MeSH:D013629) in CTD
|
|
GS1072: ZM_ACTIVITY_Chr12_98.000000-112.000000
|
|
GS135262: acute functional tolerance to ethanol QTL 1 (Afteq1, Published QTL Chr 12)
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS34626: Striatum Gene expression correlates of Novel environment distance (cm) travelled min 15-30 [Cocaine] in Males BXD
|
|
GS174657: HP:0001425 Heterogeneous
|
|
GS195844: GO:0015036 disulfide oxidoreductase activity
|
|
GS171453: HP:0003674 Onset
|
|
GS34457: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the periphery in BXD Males
|
|
GS136679: skull morphology 18 (Skull18, Published QTL Chr 12)
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS84266: METH responses for home cage activity (Published QTL, Chr 12)
|
|
GS83982: cocaine related behavior 13 (Cocrb13, Published QTL, Chr 12)
|
|
GS176041: HP:0011031 Abnormality of iron homeostasis
|
|
GS136071: insulin QTL 10 (Insq10, Published QTL Chr 12)
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS180152: GO:0065007 biological regulation
|
|
GS192224: GO:0051536 iron-sulfur cluster binding
|
|
GS129193: tibia bone quality traits 3 (Tbqt3 Published QTL Chr 12)
|
|
GS208978: GO:0043169 cation binding
|
|
GS176632: HP:0001903 Anemia
|
|
GS194284: GO:0048534 hematopoietic or lymphoid organ development
|
|
GS84265: nicotine sensitivity (Published QTL, Chr 12)
|
|
GS196806: GO:0032502 developmental process
|
|
GS135368: B.burgdorferi-associated arthritis 6 (Bbaa6, Published QTL Chr 12)
|
|
GS203594: GO:0043226 organelle
|
|
GS135680: Crhr1 transcript abundance QTL 2 (Crhr1taq2, Published QTL Chr 12)
|
|
GS135608: circulating hormone level QTL 17 (Chlq17, Published QTL Chr 12)
|
|
GS180156: GO:0065008 regulation of biological quality
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS194586: GO:0002376 immune system process
|
|
GS209157: GO:0051536 iron-sulfur cluster binding
|
|
GS175390: HP:0011007 Age of onset
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS186744: GO:0043226 organelle
|
|
GS190956: GO:0009055 electron carrier activity
|
|
GS210408: GO:0016667 oxidoreductase activity, acting on a sulfur group of donors
|
|
GS182835: GO:0005622 intracellular
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS136274: multigenic obesity QTL 3 (Mobq3, Published QTL Chr 12)
|
|
GS136846: thymic lymphoma suppressor region 6 (Tlsr6, Published QTL Chr 12)
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS177356: GO:0003674 molecular_function
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS189860: GO:0043167 ion binding
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS176610: HP:0003593 Infantile onset
|
|
GS195199: GO:0005634 nucleus
|
|
GS180166: GO:0008152 metabolic process
|
|
GS188499: GO:0051540 metal cluster binding
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS200565: GO:0019725 cellular homeostasis
|
|
GS135565: cytokine deficiency colitis susceptibility 7 (Cdcs7, Published QTL Chr 12)
|
|
GS206742: GO:0043167 ion binding
|
|
GS183767: GO:0019725 cellular homeostasis
|
|
GS135771: ear healing QTL 3 (Earheal3, Published QTL Chr 12)
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS173534: HP:0001877 Abnormality of erythrocytes
|
|
GS135991: Hfe modifier 4 (Hfem4, Published QTL Chr 12)
|
|
GS135681: Crh transcript abundance QTL 2 (Crhtaq2, Published QTL Chr 12)
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS179081: GO:0015036 disulfide oxidoreductase activity
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS172364: HP:0003111 Abnormality of ion homeostasis
|
|
GS209158: GO:0051537 2 iron, 2 sulfur cluster binding
|
|
GS181473: GO:0005488 binding
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS196930: GO:0065007 biological regulation
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS205357: GO:0051540 metal cluster binding
|
|
GS213077: Genes with suggestive difference in (PWD) vs (PB6F1 + B6PF1 + B6) comparison
|
|
GS195214: GO:0009987 cellular process
|
|
GS210170: GO:0030097 hemopoiesis
|
|
GS136529: prion disease incubation time 4 (Prdt4, Published QTL Chr 12)
|
|
GS34641: Cerebellum Gene expression correlates of Novel environment locomotion (cm) 30-45 min in the periphery in Females BXD
|
|
GS198755: GO:0016491 oxidoreductase activity
|
|
GS136123: life span 3 (Lifespan3, Published QTL Chr 12)
|
|
GS193991: GO:0048731 system development
|
|
GS174335: HP:0001871 Abnormality of blood and blood-forming tissues
|
|
GS136064: immunoregulatory 6 (Im6, Published QTL Chr 12)
|
|
GS195476: GO:0015035 protein disulfide oxidoreductase activity
|
|
GS177409: GO:0005739 mitochondrion
|
|
GS198263: GO:0005488 binding
|
|
GS34605: Striatum Gene expression correlates of Novel environment distance (cm) travelled min 15-30 in Males BXD
|
|
GS175529: HP:0000001 All
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS194138: GO:0005739 mitochondrion
|
|
GS184447: GO:0044424 intracellular part
|
|
GS190124: GO:0042592 homeostatic process
|
|
GS203335: GO:0048513 organ development
|
|
GS34606: Striatum Gene expression correlates of Novel environment distance (cm) travelled min 15-30 in BXD Males
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS123768: Cyclosporine interacting genes (MeSH:D016572) in CTD
|
|
GS180164: GO:0008150 biological_process
|
|
GS34477: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the periphery [Cocaine] in Males BXD
|
|
GS136424: pulmonary adenoma resistance 3 (Par3, Published QTL Chr 12)
|
|
GS208012: GO:0044464 cell part
|
|
GS210212: GO:0005575 cellular_component
|
|
GS135873: femur geometry 10 (Fmgty10, Published QTL Chr 12)
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS135498: BSB obesity 4 (Bsbob4, Published QTL Chr 12)
|
|
GS34456: Striatum Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the periphery in Males BXD
|
|
GS135978: wound healing/regeneration 5 (Heal5, Published QTL Chr 12)
|
|
GS207015: GO:0042592 homeostatic process
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS136930: vertebral trabecular bone trait 14 (Vtbt14, Published QTL Chr 12)
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS135226: antibody mediated myocarditis (Abmm, Published QTL Chr 12)
|
|
GS182834: GO:0005623 cell
|
|
GS178448: GO:0005634 nucleus
|
|
GS197968: GO:0045454 cell redox homeostasis
|
|
GS199635: GO:0005622 intracellular
|
|
GS195206: GO:0002520 immune system development
|
|
GS135713: diabesity 3 (Dbsty3, Published QTL Chr 12)
|
|
GS213076: Genes with suggestive difference in (B6) vs (B6PF1 + PB6F1 + PWD) comparison
|
|
GS136399: organ weight 8 (Org8, Published QTL Chr 12)
|
|
GS196941: GO:0008150 biological_process
|
|
GS199634: GO:0005623 cell
|